Study of biomarkers in lichen planus
Part of Skin clinical trials.
This study looks at people with lichen planus (a rash that can affect skin, mouth, or genitals) to find markers in cells and blood that may help understand the disease. If you have a new diagnosis or a flare-up, and you are not on strong immune-suppressing medicine, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of lichen planus or are having a flare-up of symptoms.
- You are not currently on any systemic treatment (like steroids or immune-suppressing drugs), or you have stopped them recently.
- Your lichen planus is not only on skin folds (like armpits or groin) or on your face.
- You are able to give written consent and understand spoken and written French.
- You are covered by French social security or a similar health insurance plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at what affects the “path” (trajectory) of long-lasting inflammatory skin conditions. It may help researchers understand why symptoms change and how treatments or factors influence those changes.
This study compares two medicines, methotrexate and acitretin, to see which one works better for widespread lichen planus, a skin condition that causes itchy, flat bumps. If you join, you will receive one of these treatments to help manage your symptoms.
This study looks at whether people with oral lichen planus (a chronic mouth condition) have a higher risk of heart problems or blood clots. By joining, you would help researchers understand this possible link, which could lead to better monitoring and prevention for others like you.
This study looks at a protein called desmoglein-3, which may be linked to oral lichen planus, a condition that causes painful sores in the mouth. The goal is to see if levels of this protein relate to how severe the condition is, which could help guide future treatments.
This trial tests a pill called upadacitinib to see if it can reduce painful mouth sores and scalp hair loss caused by lichen planus. It may help people who have not gotten better with topical steroid creams.
Hear when a new Lichen Planus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.